238 related articles for article (PubMed ID: 10190897)
21. Selection for drug resistance results in resistance to Fas-mediated apoptosis.
Landowski TH; Gleason-Guzman MC; Dalton WS
Blood; 1997 Mar; 89(6):1854-61. PubMed ID: 9058704
[TBL] [Abstract][Full Text] [Related]
22. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis.
Kamihira S; Yamada Y; Hirakata Y; Tomonaga M; Sugahara K; Hayashi T; Dateki N; Harasawa H; Nakayama K
Br J Haematol; 2001 Jul; 114(1):63-9. PubMed ID: 11472346
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation.
Liu C; Cheng J; Mountz JD
Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):957-63. PubMed ID: 7575433
[TBL] [Abstract][Full Text] [Related]
25. Lack of Fas (APO-1/CD95) gene structural alterations or transcript variant ratio changes in breast cancer.
Puiu L; Petrakou E; Apostolidou A; Athanassiadou A; Psiouri L; Papachatzopoulou A; Gorgoulis VG; Kotsinas A; Tzoracoeleftherakis E; Maniatis GM; Voutsinas G
Cancer Lett; 2003 May; 194(1):91-7. PubMed ID: 12706862
[TBL] [Abstract][Full Text] [Related]
26. Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation.
Shinohara H; Yagita H; Ikawa Y; Oyaizu N
Cancer Res; 2000 Mar; 60(6):1766-72. PubMed ID: 10749152
[TBL] [Abstract][Full Text] [Related]
27. [Fas antigen (CD95) expressions and apoptosis of neoplastic cells from various lymphoid malignancies including adult T-cell leukemia/lymphoma].
Sasao T; Yoshida M; Ichikawa Y
Nihon Rinsho; 1996 Jul; 54(7):1986-91. PubMed ID: 8741700
[TBL] [Abstract][Full Text] [Related]
28. Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene.
Watanabe T; Yamaguchi K; Takatsuki K; Osame M; Yoshida M
J Exp Med; 1990 Sep; 172(3):759-65. PubMed ID: 2388034
[TBL] [Abstract][Full Text] [Related]
29. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells.
Oshimi Y; Oda S; Honda Y; Nagata S; Miyazaki S
J Immunol; 1996 Oct; 157(7):2909-15. PubMed ID: 8816396
[TBL] [Abstract][Full Text] [Related]
30. Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers.
Berneman ZN; Gartenhaus RB; Reitz MS; Blattner WA; Manns A; Hanchard B; Ikehara O; Gallo RC; Klotman ME
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3005-9. PubMed ID: 1348363
[TBL] [Abstract][Full Text] [Related]
31. Dominant-negative Fas mutation is reversed by down-expression of c-FLIP.
Bénéteau M; Daburon S; Moreau JF; Taupin JL; Legembre P
Cancer Res; 2007 Jan; 67(1):108-15. PubMed ID: 17210689
[TBL] [Abstract][Full Text] [Related]
32. Profiles of expression of activated cell antigens on peripheral blood and lymph node cells from different clinical stages of adult T-cell leukemia.
Shirono K; Hattori T; Hata H; Nishimura H; Takatsuki K
Blood; 1989 May; 73(6):1664-71. PubMed ID: 2713499
[TBL] [Abstract][Full Text] [Related]
33. Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis.
Cascino I; Papoff G; De Maria R; Testi R; Ruberti G
J Immunol; 1996 Jan; 156(1):13-7. PubMed ID: 8598453
[TBL] [Abstract][Full Text] [Related]
34. Soluble and membrane isoforms of Fas/CD95 in fresh adult T-cell leukemia (ATL) cells and ATL-cell lines.
Sugahara K; Yamada Y; Hiragata Y; Matsuo Y; Tsuruda K; Tomonaga M; Maeda T; Atogami S; Tsukasaki K; Kamihira S
Int J Cancer; 1997 Jul; 72(1):128-32. PubMed ID: 9212233
[TBL] [Abstract][Full Text] [Related]
35. Modulation of fas-mediated apoptosis in osteosarcoma cell lines.
Hamada T; Komiya S; Yano H; Zenmyo M; Hiraoka K; Inoue A; Morimatsu M
Int J Oncol; 1999 Dec; 15(6):1125-31. PubMed ID: 10568818
[TBL] [Abstract][Full Text] [Related]
36. Over-expressed Fas improves the apoptosis of malignant T-cells in vitro and vivo.
Li L; Zhang R; Chen Z; Xue S; Wang X; Ruan C
Mol Biol Rep; 2011 Nov; 38(8):5371-7. PubMed ID: 21390503
[TBL] [Abstract][Full Text] [Related]
37. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.
Yao H; Song E; Chen J; Hamar P
Br J Cancer; 2004 Nov; 91(9):1718-25. PubMed ID: 15494722
[TBL] [Abstract][Full Text] [Related]
38. Fas expression and Fas monoclonal antibody-induced apoptosis in a human squamous cell carcinoma cell line, SCC-25.
Seta C; Fujita M; Muraki Y; Fukuda J; Kobayashi S; Haneji T
J Oral Pathol Med; 2000 Jul; 29(6):271-8. PubMed ID: 10890558
[TBL] [Abstract][Full Text] [Related]
39. Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309.
Ruckes T; Saul D; Van Snick J; Hermine O; Grassmann R
Blood; 2001 Aug; 98(4):1150-9. PubMed ID: 11493464
[TBL] [Abstract][Full Text] [Related]
40. CD69 overexpression by human T-cell leukemia virus type 1 Tax transactivation.
Ishikawa C; Kawakami H; Uchihara JN; Senba M; Mori N
Biochim Biophys Acta; 2013 Jun; 1833(6):1542-52. PubMed ID: 23507197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
